Mayne Pharma to be Acquired by Cosette Pharmaceuticals

Mayne Pharma Group ( (AU:MYX) ) has shared an update.

Mayne Pharma Group Limited has entered into a Scheme Implementation Deed with Cosette Pharmaceuticals Inc, under which Cosette will acquire 100% of Mayne Pharma’s shares through a scheme of arrangement. The company has been sharing information with Cosette as part of this agreement, including a non-material Untitled Letter related to a speaker presentation for NEXTSTELLIS®. Mayne Pharma confirmed that the letter does not impact its ability to sell and distribute NEXTSTELLIS® in the United States and does not consider it materially price sensitive, thus not requiring market disclosure.

The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.

More about Mayne Pharma Group

Mayne Pharma Group Limited is a pharmaceutical company that focuses on developing and manufacturing branded and generic pharmaceutical products. The company is involved in the distribution of its products across various markets, with a particular emphasis on the United States.

Average Trading Volume: 811,987

Technical Sentiment Signal: Buy

Current Market Cap: A$526.5M

Find detailed analytics on MYX stock on TipRanks’ Stock Analysis page.